Top Analyst Downgrades and Stocks to Sell: CVS, DaVita, Zillow and More

August 7, 2013 by Jon C. Ogg

Bull and Bear
Source: Jon Ogg
Investors frequently get to see the analyst upgrades and Buy ratings from Wall Street firms. What investors often do not get to see is when analyst downgrade stocks to sell or to avoid. 24/7 Wall St. reviews many fresh research calls each and every day to find great ideas from value stocks to growth stocks to dividend stocks, and we have broken out the negative analyst calls. These are this Wednesday’s top analyst downgrades and cautious research notes from Wall Street.

CVS Caremark Corp. (NYSE: CVS) was downgraded to Hold from Buy at Cantor Fitzgerald.

DaVita Healthcare Partners Inc. (NYSE: DVA) was downgraded to Sector Perform from Outperform at RBC Capital Markets.

Endeavour International Corp. (NYSE: END) was downgraded to Hold from Buy at Canaccord Genuity.

Endo Health Solutions Inc. (NASDAQ: ENDP) was downgraded to Sell from an already cautious Neutral rating at Janney.

Five Oaks Investment Corp. (NYSE: OAKS) was downgraded to Neutral from Outperform at Credit Suisse.

Marathon Oil Corp. (NYSE: MRO) was downgraded to Neutral from Buy at BofA/Merrill Lynch.

Zillow Inc. (NASDAQ: Z) was downgraded to Sector Perform from Outperform at RBC Capital Markets.

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.

Posted in Investing | Comments Off on Top Analyst Downgrades and Stocks to Sell: CVS, DaVita, Zillow and More